Get a job referral to Editas Medicine
Massachusetts, United States
201-500 Employees
Healthcare
•Tech
Description
Editas Medicine (NASDAQ: EDIT) is a leading biotechnology company that specializes in genome editing. Founded with a vision to harness the power of CRISPR technology, Editas Medicine is at the forefront of developing innovative therapies to address genetic diseases. Their groundbreaking research and development efforts have the potential to revolutionize the field of medicine by offering targeted treatments for a wide range of genetic disorders. Editas Medicine is dedicated to advancing precision medicine and improving patient outcomes through cutting-edge genome editing technologies.
Editas Medicine
Senior Director, Process Development
Editas Medicine
Scientist II, Molecular Biology & Gene Editing
Editas Medicine
Associate Corporate Counsel
Editas Medicine
Scientist I, In Vivo Discovery
Editas Medicine
Gene Editing Expert
Editas Medicine
Associate Corporate
Editas Medicine
Legal Counsel in Gene Editing
Editas Medicine
Associate Corporate Counsel
Editas Medicine
Research Associate, Molecular Bioanalytics
Editas Medicine
Senior Formulation Scientist
Financials
Type
public
Annual Revenue
--
Market Cap
$115.3M+
Subscribe to Refer Me premium to get referred to your dream role at Editas Medicine!
